論文種別 | 原著(症例報告除く) |
言語種別 | 英語 |
査読の有無 | その他(不明) |
表題 | Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab-Treated HCC |
掲載誌名 | 正式名:Journal of gastroenterology and hepatology 略 称:J Gastroenterol Hepatol ISSNコード:08159319/14401746 |
掲載区分 | 国外 |
巻・号・頁 | 40(4),pp.949-959 |
著者・共著者 | Matono T, Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J,
Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tanaka K, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Aoki T, Kuroda H, Yata Y, Nakamura Y, Yoshida O, Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M; Real‐life Practice Experts for HCC (RELPEC) Study Group; Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. |
発行年月 | 2025/04 |
DOI | 10.1111/jgh.16884 |
PMID | 39844393 |